MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04133naaaa2200913uu 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
https://directory.doabooks.org/handle/20.500.12854/40955 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220714190324.0 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
books978-3-03921-587-4 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039215867 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039215874 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.3390/books978-3-03921-587-4 |
| Terms of availability |
doi |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
dc |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
O'Boyle, Niamh M |
| Relator code |
auth |
| 9 (RLIN) |
1590485 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Anticancer Drugs |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
| Date of publication, distribution, etc |
2019 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 electronic resource (214 p.) |
| 506 0# - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Open Access |
| Source of term |
star |
| Standardized terminology for access restriction |
Unrestricted online access |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
The past decades have seen major developments in the understanding of the cellular and molecular biology of cancer. Significant progress has been achieved regarding long-term survival for the patients of many cancers with the use of tamoxifen for treatment of breast cancer, treatment of chronic myeloid leukaemia with imatinib, and the success of biological drugs. The transition from cytotoxic chemotherapy to targeted cancer drug discovery and development has resulted in an increasing selection of tools available to oncologists. In this Special Issue of Pharmaceuticals, we highlight the opportunities and challenges in the discovery and design of innovative cancer therapies, novel small-molecule cancer drugs and antibody-drug conjugates, with articles covering a variety of anticancer therapies and potential relevant disease states and applications. Significant efforts are being made to develop and improve cancer treatments and to translate basic research findings into clinical use, resulting in improvements in survival rates and quality of life for cancer patients. We demonstrate the possibilities and scope for future research in these areas and also highlight the challenges faced by scientists in the area of anticancer drug development leading to improved targeted treatments and better survival rates for cancer patients. |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
|---|
| Terms governing use and reproduction |
Creative Commons |
| -- |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| -- |
cc |
| -- |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
graphene oxide |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
indole |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
androgens |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cyclooxygenase-2 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cyclooxygenase-1 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
heteropolysaccharide |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
drug conjugation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
drug delivery |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
ellipticine |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
chemical linker |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
oesophageal cancer |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
antiproliferative activity |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
topoisomerase II |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
?-lactam |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
DSD |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
antibody |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
topoisomerase inhibitors |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
magnetic targeting |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cisplatin resistance |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
steroidogenesis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
[18F]FDG PET/CT |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
heterocyclic chemistry |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
dehydroepiandrosterone |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
antimitotic |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
3-vinylazetidin-2-ones |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
glioblastoma |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
and cancer therapy |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
intestinal mucositis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Combretastatin A-4 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
metabolism |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
anti-cancer drugs |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
maghemite |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
COX-1 inhibitor |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
anticancer |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
CYP17A1 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
conjugate and hybrid drugs |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
inflammation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
snticancer drugs |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
P450c17 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
tumorigenesis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cisplatin |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
biomarker profiling |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cancer drug design |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
tubulin |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cytochrome P450 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
5-fluorouracil |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
prostate cancer |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
abiraterone |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
NCI screen |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
radiation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cancer immunotherapy |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
microtubule targeted drugs |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cancer |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
treatment resistance |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Meegan, Mary J |
| Relator code |
auth |
| 9 (RLIN) |
1590484 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/1662">https://mdpi.com/books/pdfview/book/1662</a> |
| -- |
0 |
| Public note |
DOAB: download the publication |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/40955">https://directory.doabooks.org/handle/20.500.12854/40955</a> |
| -- |
0 |
| Public note |
DOAB: description of the publication |
